These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17199818)

  • 1. Heterozygote carrier testing in high schools abroad: what are the lessons for the U.S.?
    Ross LF
    J Law Med Ethics; 2006; 34(4):753-64. PubMed ID: 17199818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
    Broide E; Zeigler M; Eckstein J; Bach G
    Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.
    Lew RM; Proos AL; Burnett L; Delatycki M; Bankier A; Fietz MJ
    Med J Aust; 2012 Dec; 197(11):652-4. PubMed ID: 23230938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population screening for reproductive risk for single gene disorders in Australia: now and the future.
    Delatycki MB
    Twin Res Hum Genet; 2008 Aug; 11(4):422-30. PubMed ID: 18637742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal.
    Zeesman S; Clow CL; Cartier L; Scriver CR
    Am J Med Genet; 1984 Aug; 18(4):769-78. PubMed ID: 6486173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the potential success of cystic fibrosis carrier screening: lessons learned from Tay-Sachs disease and beta-thalassemia.
    Laberge AM; Watts C; Porter K; Burke W
    Public Health Genomics; 2010; 13(5):310-9. PubMed ID: 19864874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools.
    Ioannou L; Massie J; Lewis S; Petrou V; Gason A; Metcalfe S; Aitken MA; Bankier A; Delatycki MB
    Clin Genet; 2010 Jul; 78(1):21-31. PubMed ID: 20597919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Tay-Sachs disease screening program in the U.S. as a model for the control of genetic disease: an historical view.
    Edelson PJ
    Health Matrix Clevel; 1997; 7(1):125-33. PubMed ID: 10167171
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of a school-based Tay-Sachs and cystic fibrosis genetic carrier screening program.
    Warren E; Anderson R; Proos AL; Burnett LB; Barlow-Stewart K; Hall J
    Genet Med; 2005 Sep; 7(7):484-94. PubMed ID: 16170240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools.
    Mitchell JJ; Capua A; Clow C; Scriver CR
    Am J Hum Genet; 1996 Oct; 59(4):793-8. PubMed ID: 8808593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tay-Sachs disease carrier screening: a 21-year experience.
    D'Souza G; McCann CL; Hedrick J; Fairley C; Nagel HL; Kushner JD; Kessel R
    Genet Test; 2000; 4(3):257-63. PubMed ID: 11142756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease].
    Peleg L; Gazit E; Goldman B; Akstein E
    Harefuah; 1995 Dec; 129(11):475-80. PubMed ID: 8846957
    [No Abstract]   [Full Text] [Related]  

  • 13. The control of genetic disease by carrier screening and antenatal diagnosis: social, ethical, and medicolegal issues.
    Kaback MM
    Birth Defects Orig Artic Ser; 1982; 18(7):243-54. PubMed ID: 7159734
    [No Abstract]   [Full Text] [Related]  

  • 14. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students.
    Barlow-Stewart K; Burnett L; Proos A; Howell V; Huq F; Lazarus R; Aizenberg H
    J Med Genet; 2003 Apr; 40(4):e45. PubMed ID: 12676918
    [No Abstract]   [Full Text] [Related]  

  • 16. Population programs for the detection of couples at risk for severe monogenic genetic diseases.
    Zlotogora J
    Hum Genet; 2009 Aug; 126(2):247-53. PubMed ID: 19390864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimedia messages in genetics: design, development, and evaluation of a computer-based instructional resource for secondary school students in a Tay Sachs disease carrier screening program.
    Gason AA; Aitken M; Delatycki MB; Sheffield E; Metcalfe SA
    Genet Med; 2004; 6(4):226-31. PubMed ID: 15266211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Tay-Sachs disease screening program.
    Gason AA; Sheffield E; Bankier A; Aitken MA; Metcalfe S; Barlow Stewart K; Delatycki MB
    Clin Genet; 2003 May; 63(5):386-92. PubMed ID: 12752571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Tay-Sachs disease: a note of caution.
    Rosner F
    J Clin Ethics; 1991; 2(4):251-2. PubMed ID: 1804394
    [No Abstract]   [Full Text] [Related]  

  • 20. The ovrselling of genetic anxiety.
    Goodman MJ; Goodman LE
    Hastings Cent Rep; 1982 Oct; 12(5):20-7. PubMed ID: 7174291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.